1. Risk of death in patients with coronary artery disease taking nitrates and phosphodiesterase-5 inhibitors;Trolle;J Am Coll Cardiol,2024
2. Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health;Kloner;J Sex Med,2024
3. Cardiovascular outcome risks in patients with erectile dysfunction co-prescribed a phosphodiesterase type 5 inhibitor (PDE5i) and a nitrate: a retrospective observational study using electronic health record data in the United States;Nunes;J Sex Med,2021
4. Adverse events associated with coprescription of phosphodiesterase type 5 inhibitors and oral organic nitrates in male patients with ischemic heart disease: a case-crossover study;Holt;Ann Intern Med,2022